COVID-19 rapidly reshaping HIV services around the world
UK sexual health services are being decimated by COVID-19
HIV is low on the list of co-morbidities among coronavirus patients in New York
HIV prevention trials paused during coronavirus crisis
Changes in fat cells on HIV treatment may have long-term metabolic consequences
Integrase inhibitors may be associated with a lower risk of cardiovascular disease than NNRTIs and protease inhibitors
Community networks playing a central role in ensuring access to HIV treatment during India’s COVID-19 lockdown
COVID-19 in Barcelona: first cases in people living with HIV reported
Cardiovascular disease in people living with HIV in Africa under-studied, prevention neglected
